Ronald Yamamoto

Company: Oxular

Job title: Chief Scientific Officer

Seminars:

Delivering Targeted Long-Lasting Sustained Release Retinal Treatments Using Novel Suprachoroidal Injection 8:30 am

Minimally invasive suprachoroidal catheterization device for improved patient care Clinical trials updates on suprachoroidal device administering sustained release dexamethasone drug product Exploring drug formulation properties for successful retinal drug delivery via suprachoroidal injectionRead more

day: Conference Day Two